✦ LIBER ✦

Use of a radiolabeled monoclonal antibody against e-selectin for imaging of endothelial activation in rheumatoid arthritis

✍ Scribed by Peter T. Chapman; François Jamar; Edward T. M. Keelan; A. Michael Peters; Dorian O. Haskard

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 529 KB
Volume: 39
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780390815

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo fluorescence imaging of E-select

In vivo fluorescence imaging of E-selectin: Quantitative detection of endothelial activation in a mouse model of arthritis

✍ Luke L. Gompels; Leigh Madden; Ngee Han Lim; Julia J. Inglis; Ellen McConnell; T 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 785 KB

Adalimumab, a fully human anti–tumor nec

Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

✍ Michael E. Weinblatt; Edward C. Keystone; Daniel E. Furst; Larry W. Moreland; Mi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

Erratum: Golimumab, a human anti-tumor n

Erratum: Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views

Erratum: M.E. Weinblatt, E.C. Keystone,

Erratum: M.E. Weinblatt, E.C. Keystone, D.E. Furst, L.W. Moreland, M.H. Weisman, C.A. Birbara, L.A. Teoh, S.A. Fischkoff, and E.K. Chartash. Adalimumab, a Fully Human Anti-Tumor Necrosis Factor α Monoclonal Antibody, for the Treatment of Rheumatoid Arthritis in Patients Taking Concomitant Methotrexate: The ARMADA Trial, Arthritis & Rheumatism (2003) 48(1) 35-45.

📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

## Abstract The original article to which this Erratum refers was published in Arthritis & Rheumatism(2003) 48(1) 35–45 In the article by Weinblatt et al published in the January 2003 issue of __Arthritis & Rheumatism__ (pp 35–45), there was an error in data reported in the first paragraph of the